Tirzepatide, a recently approved medication, is showing significant promise as a groundbreaking treatment for individuals diagnosed with diabetes of type 2. Unlike existing diabetes drugs , it functions through a dual mechanism, activating both glucagon-like peptide-1 and glucose-dependent insuli